Registration is open for the 2024 ASRM Scientific Congress & Expo
On Wednesday, August 16, a federal appeals court said the FDA overstepped its authority when it made the drug more accessible and ruled to limit access to the abortion pill.
On Friday, April 7, a single, federal judge in Texas issued a ruling that stays, for one week, FDA approval of mifepristone, effectively removing it from the market. Since the passage of the Pure
Mississippi laws that may have a potential impact on IVF/Reproductive medicine
New Hampshire laws that may have a potential impact on IVF/Reproductive medicine
South Dakota laws that may have a potential impact on IVF/Reproductive medicine
North Dakota laws that may have a potential impact on IVF/Reproductive medicine
Ohio laws that may have a potential impact on IVF/Reproductive medicine
Nebraska laws that may have a potential impact on IVF/Reproductive medicine
Minnesota laws that may have a potential impact on IVF/Reproductive medicine
Idaho laws that may have a potential impact on IVF/Reproductive medicine
Displaying 701 to 710 of 1247 records